Clinical Trial Update: Norovirus Bivalent-Vaccine Efficacy Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for a norovirus bivalent vaccine assessing prevention of norovirus infection; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Infection
• Prevention of Norovirus Infection

Drugs mentioned

• Norovirus Bivalent Vaccine

Snippet

Sponsor: Takeda | Conditions: Prevention From Norovirus Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-15